Hjem › Eggstokkreft › New Hampshire
Kliniske studier for Eggstokkreft i New Hampshire
4 studier for Eggstokkreft søker deltakere på steder i New Hampshire.
Offisiell studietekst (engelsk)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Dartmouth-Hitchcock Medical Center /ID# 274676, Lebanon
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 29. sep. 2026 · NCT06890338A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Dartmouth-Hitchcock Medical Center, Lebanon
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213804A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Rekrutterer
Alder 35 til 50 · Kvinner · Oppdatert 7. aug. 2026 · NCT04251052Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
- Dartmouth Hitchcock, Lebanon
- Dartmouth-Hitchcock Manchester, Manchester
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 28. jan. 2026 · NCT06815497Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.